Group Manager of Cell BiologyZhengzhou Gensciences Inc., Zhengzhou, ChinaZhengzhou, Henan, China (People's Republic)
OC 21.3 - The in vitro and in vivo hemostatic efficacies of a novel FVIIIa-mimetic bispecific antibody, SS315, for the treatment of Hemophilia A.
Sunday, June 23, 202415:15 – 15:30 ICT